|
|
FDA Requests Recall of Xiadafil VIP Tabs
Product contains undeclared ingredient that puts consumer health at risk
The U.S. Food and Drug Administration today requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person's blood pressure and can cause other life-threatening side effects. These lots of Xiadafil VIP Tabs bear an expiration date of September 2009 (09/09). Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and able to treat erectile dysfunction (ED).
Xiadafil VIP Tabs are an illegally marketed drug
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01840.html
|
